{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:45:24Z","timestamp":1793389524878,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.metabol.2020.154455","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T01:15:52Z","timestamp":1606612552000},"page":"154455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"special_numbering":"C","title":["The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"115","author":[{"given":"Dimitrios A.","family":"Koutoukidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Koshiaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Noreik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrani","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bodenham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dunnigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Jebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Aveyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154455_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154455_bb0010","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/hep.30125","article-title":"Patient-reported outcomes and the economic effects of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: the value proposition","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154455_bb0015","doi-asserted-by":"crossref","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2020.154455_bb0020","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.3748\/wjg.v22.i31.7006","article-title":"Metabolic aspects of adult patients with nonalcoholic fatty liver disease","volume":"22","author":"Abenavoli","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154455_bb0030","doi-asserted-by":"crossref","first-page":"e1008405","DOI":"10.1371\/journal.pgen.1008405","article-title":"Causal relationships between obesity and the leading causes of death in women and men","volume":"15","author":"Censin","year":"2019","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2020.154455_bb0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cgh.2018.07.006","article-title":"Obesity and weight gain are associated with progression of fibrosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Kim","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2020.154455_bb0040","doi-asserted-by":"crossref","first-page":"e025045","DOI":"10.1136\/bmjopen-2018-025045","article-title":"Top research priorities in liver and gallbladder disorders in the UK","volume":"9","author":"Gurusamy","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.metabol.2020.154455_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2020.154455_bb0050","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2019.2248","article-title":"Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis","author":"Koutoukidis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.metabol.2020.154455_bb0060","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2020.154455_bb0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.soard.2018.12.002","article-title":"Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis","volume":"15","author":"Fakhry","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.metabol.2020.154455_bb0070","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2020.154455_bb0075","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.metabol.2020.154455_bb0080","first-page":"7","article-title":"Short-term hypocaloric high-fiber and high-protein diet improves hepatic steatosis assessed by controlled attenuation parameter","author":"Arslanow","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0085","series-title":"Covidence Systematic Review Software","author":"Cochrane","year":"2019"},{"key":"10.1016\/j.metabol.2020.154455_bb0090","first-page":"1","article-title":"Standardised regression coefficient as an effect size index in summarising findings in epidemiological studies","volume":"10","author":"Nieminen","year":"2013","journal-title":"Epidemiol Biostat Public Health"},{"key":"10.1016\/j.metabol.2020.154455_bb0095","article-title":"A century of trends in adult human height","volume":"5","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.metabol.2020.154455_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.metabol.2020.154455_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.metabol.2020.154455_bb0110","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/10408398.2018.1507996","article-title":"The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials","volume":"59","author":"Tabrizi","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.metabol.2020.154455_bb0115","first-page":"40","article-title":"meta: an R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R News"},{"key":"10.1016\/j.metabol.2020.154455_bb0120","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1572-0241.2006.00419.x","article-title":"Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery","volume":"101","author":"Barker","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000375506","article-title":"Effect on liver enzymes of biliopancreatic diversion: 4 years of follow-up","volume":"66","author":"Aller","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.metabol.2020.154455_bb0130","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00464-015-4426-0","article-title":"Non-alcoholic fatty liver disease resolution following sleeve gastrectomy","volume":"30","author":"Algooneh","year":"2016","journal-title":"Surg Endosc"},{"key":"10.1016\/j.metabol.2020.154455_bb0135","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11695-016-2482-8","article-title":"Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease","volume":"27","author":"Ooi","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2020.154455_bb0140","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1381\/096089206778663805","article-title":"Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement","volume":"16","author":"Dixon","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2020.154455_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11695-008-9690-9","article-title":"Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding","volume":"19","author":"Gastaldelli","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2020.154455_bb0150","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1148\/radiol.2018181134","article-title":"Monitoring fatty liver disease with MRI following bariatric surgery: a prospective, dual-center study","volume":"290","author":"Pooler","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.metabol.2020.154455_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2020.154455_bb0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154455_bb0165","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s10620-006-9631-1","article-title":"Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH)","volume":"52","author":"Hussein","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.metabol.2020.154455_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819879047","article-title":"Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction","volume":"12","author":"Ye","year":"2019","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2006.02.004","article-title":"A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease","volume":"4","author":"Zelber-Sagi","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2020.154455_bb0180","doi-asserted-by":"crossref","first-page":"e50117","DOI":"10.1371\/journal.pone.0050117","article-title":"Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists","volume":"7","author":"Cuthbertson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2020.154455_bb0185","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/dom.13007","article-title":"Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: a pilot randomized trial","volume":"19","author":"Khoo","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2020.154455_bb0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/TCRM.S124621","article-title":"Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients","volume":"13","author":"Ali Khan","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.metabol.2020.154455_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154455_bb0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2478\/jtim-2019-0023","article-title":"Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient","volume":"7","author":"Alam","year":"2019","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.metabol.2020.154455_bb0205","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-2036.2009.04122.x","article-title":"Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease","volume":"30","author":"Vilar Gomez","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2020.154455_bb0210","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1007\/s00125-020-05265-7","article-title":"Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)","volume":"63","author":"Kuchay","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2020.154455_bb0215","article-title":"Intragastric balloon placement induces significant metabolic and histologic improvement in patients with nonalcoholic steatohepatitis","author":"Bazerbachi","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2020.154455_bb0220","doi-asserted-by":"crossref","first-page":"e00231","DOI":"10.14309\/ctg.0000000000000231","article-title":"Feasibility of a very low calorie diet to achieve a sustainable 10% weight loss in patients with nonalcoholic fatty liver disease","volume":"11","author":"Scragg","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0225","first-page":"54","article-title":"Noninvasive markers of improvement of liver steatosis achieved by weight reduction in patients with nonalcoholic fatty liver disease","volume":"53","author":"Copaci","year":"2015","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.metabol.2020.154455_bb0230","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1665-2681(19)31517-0","article-title":"Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet","volume":"10","author":"Rodriguez-Hernandez","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.metabol.2020.154455_bb0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4314\/ahs.v16i1.32","article-title":"Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis","volume":"16","author":"Abd El-Kader","year":"2016","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.metabol.2020.154455_bb0240","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3748\/wjg.v25.i9.1116","article-title":"Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis","volume":"25","author":"Deibert","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0245","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0250","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1478-3231.2008.01742.x","article-title":"Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study","volume":"28","author":"Catalano","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2020.154455_bb0255","first-page":"9","article-title":"Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study","author":"Abenavoli","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2020.154455_bb0260","first-page":"1247","article-title":"Comparison of a commercially available, formula-based nutritional therapy enriched with oats fiber with a non-formula isocaloric therapy to treat non-alcoholic fatty liver disease (NAFLD) - a randomized, controlled intervention trial","volume":"56","author":"Schweinlin","year":"2018","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154455_bb0265","first-page":"35","article-title":"Oxidized lipid products as a marker of successful dietary intervention in NAFLD patients","volume":"4","author":"Stachowska","year":"2019","journal-title":"Inflamm Intest Dis"},{"key":"10.1016\/j.metabol.2020.154455_bb0270","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/lt.20172","article-title":"The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation","volume":"10","author":"Hwang","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.metabol.2020.154455_bb0275","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1872-034X.2010.00724.x","article-title":"Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease","volume":"40","author":"Iwasa","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.metabol.2020.154455_bb0280","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/S0140-6736(17)30647-5","article-title":"Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial","volume":"389","author":"Ahern","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2020.154455_bb0285","article-title":"Effect of Roux-en-Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity","volume":"6","author":"Sacks","year":"2018","journal-title":"Phys Rep"},{"key":"10.1016\/j.metabol.2020.154455_bb0290","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ijo.2017.31","article-title":"Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis","volume":"41","author":"Merlotti","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2020.154455_bb0295","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.clnu.2018.09.022","article-title":"Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: review and meta-analyses","volume":"38","author":"Ahn","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.metabol.2020.154455_bb0300","doi-asserted-by":"crossref","first-page":"154183","DOI":"10.1016\/j.metabol.2020.154183","article-title":"Established and emerging factors affecting the progression of nonalcoholic fatty liver disease","volume":"111S","author":"Kechagias","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2020.154455_bb0305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/DMSO.S182331","article-title":"Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease","volume":"12","author":"Szanto","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.metabol.2020.154455_bb0310","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2020.154455_bb0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/oby.20662","article-title":"Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study","volume":"22","author":"Look","year":"2014","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2020.154455_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)31893-1","article-title":"Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial","author":"Aveyard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2020.154455_bb0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/oby.20968","article-title":"The influence of an individual\u2019s weight perception on the acceptance of bariatric surgery","volume":"23","author":"Stanford","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2020.154455_bb0330","doi-asserted-by":"crossref","first-page":"k3760","DOI":"10.1136\/bmj.k3760","article-title":"Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET): pragmatic randomised controlled trial","volume":"362","author":"Astbury","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2020.154455_bb0335","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2020.154455_bb0340","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2018.07.003","article-title":"Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for beta cell recovery","volume":"28","author":"Taylor","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2020.154455_bb0345","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.2337\/dc13-0102","article-title":"Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss","volume":"36","author":"Haufe","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952030319X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952030319X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:26:37Z","timestamp":1758428797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952030319X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":69,"alternative-id":["S002604952030319X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154455","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154455"}}